Diagnosis of Hemophilia and Other Bleeding Disorders A LABORATORY MANUAL Second Edition Steve Kitchen Angus McCraw Marión Echenagucia Published by the World Federation of Hemophilia (WFH) © World Federation of Hemophilia, 2010 The WFH encourages redistribution of its publications for educational purposes by not-for-profit hemophilia organizations. For permission to reproduce or translate this document, please contact the Communications Department at the address below. This publication is accessible from the World Federation of Hemophilia’s website at www.wfh.org. Additional copies are also available from the WFH at: World Federation of Hemophilia 1425 René Lévesque Boulevard West, Suite 1010 Montréal, Québec H3G 1T7 CANADA Tel.: (514) 875-7944 Fax: (514) 875-8916 E-mail: [email protected] Internet: www.wfh.org Diagnosis of Hemophilia and Other Bleeding Disorders A LABORATORY MANUAL Second Edition (2010) Steve Kitchen Angus McCraw Marión Echenagucia WFH Laboratory WFH Laboratory (co-author, Automation) Training Specialist Training Specialist Banco Municipal Sheffield Haemophilia Katharine Dormandy de Sangre del D.C. and Thrombosis Centre Haemophilia Centre Universidad Central Royal Hallamshire and Thrombosis Unit de Venezuela Hospital The Royal Free Hospital Caracas, Venezuela Sheffield, U.K. London, U.K. on behalf of The WFH Laboratory Sciences Committee Chair (2010): Steve Kitchen, Sheffield, U.K. Deputy Chair: Sukesh Nair, Vellore, India This edition was reviewed by the following, who at the time of writing were members of the World Federation of Hemophilia Laboratory Sciences Committee: Mansoor Ahmed Clarence Lam Norma de Bosch Sukesh Nair Ampaiwan Chuansumrit Alison Street Marión Echenagucia Alok Srivastava Andreas Hillarp Some sections were also reviewed by members of the World Federation of Hemophilia von Willebrand Disease and Rare Bleeding Disorders Committee. Acknowledgement: Several of the methods described are based on laboratory standard operating procedures drafted by Annette Bowyer at the Sheffield Haemophilia Centre, whose contribution is therefore gratefully acknowledged. Cautionary Note: Where a commercial source is given in this manual, it is an example suitable at the time of writing. This is not intended as an endorsement by the World Federation of Hemophilia (WFH), the authors, or the WFH Laboratory Sciences Committee. Nor does it indicate that other sources are unreliable or unsuitable in any way. Manufacturers of materials used in laboratory tests may alter the composition of materials. Therefore, the future reliability of these sources is unknown at the time of writing. Author contact information [email protected] [email protected] Contents Contents 1 Laboratory Equipment ............................................................................................... 1 2 Checking Pipette and Weighing Balance Calibration ........................................ 3 3 Laboratory Safety ......................................................................................................... 5 4 Sample Collection and Pre-Analytical Variables .............................................. 11 5 Internal Quality Control and External Quality Assessment .......................... 14 6 Manual Tilt-Tube Technique ................................................................................... 20 7 Preparation and Calibration of Pooled Normal Plasma (PNP) .................... 22 8 Establishing a Normal Reference Range ............................................................. 24 9 Reagents ....................................................................................................................... 28 10 Platelet Count ............................................................................................................. 30 11 Bleeding Time ............................................................................................................. 35 12 Prothrombin Time (PT) ............................................................................................ 37 13 Activated Partial Thromboplastin Time (APTT) ............................................... 40 14 Mixing Tests For Further Investigation of Abnormal PT and APTT ........... 45 15 Thrombin Clotting Time .......................................................................................... 49 16 Thrombin Time in the Presence of Protamine Sulphate to Detect Presence of Heparin .................................................................................................. 51 17 Reptilase Time ............................................................................................................. 52 18 Fibrinogen (Modifi ed Clauss Assay) .................................................................... 55 19 Removal of Heparin from Plasma ......................................................................... 58 20 Fibrinogen Antigen Assay by Radial Immunodiffusion (RID) ..................... 60 21 Factor XIII Screen ....................................................................................................... 62 22 Assays Based on Prothrombin Time (Factors II, V, VII, or X) ........................ 64 23 Factor Assays Based on APTT (One-Stage Assay of FVIII:C, FIX, FXI, or FXII) ................................................................................................................. 67 24 Factor VIII:C Assays in Cryoprecipitate .............................................................. 70 25 Two-Stage Clotting Assay for Factor VIII:C ....................................................... 71 25.1 Production of Combined Reagent for Two-Stage Factor FVIII:C Assay ....... 73 26 Chromogenic FVIII:C Assay .................................................................................. 76 27 One-Stage Intrinsic Assay of Prekallikrein (PKK) and High Molecular Weight Kininogen (HMWK) .............................................................. 79 28 Clotting Factor Inhibitor Screen Based on APTT .............................................. 81 29 Ristocetin Cofactor Activity/von Willebrand Factor Activity (VWF: RCo or VWF:Act) .......................................................................................... 83 29.1 Fixed Platelet Preparation ................................................................................... 85 30 Von Willebrand Factor Antigen by Elisa (VWF:Ag) ........................................ 87 31 Von Willebrand Factor Collagen Binding Assay (VWF:CB) .......................... 90 32 Factor VIII Binding Assay for Diagnosis of von Willebrand Disease Normandy .................................................................................................... 93 33 VWF Multimer Analysis ......................................................................................... 99 34 Quantitative Measurement of FVIII Inhibitors ................................................ 108 35 Factor IX Inhibitor Assay ....................................................................................... 113 36 Factor XIII Activity Assay...................................................................................... 114 37 Lupus Anticoagulant and Anti-Phospholipid Antibodies ........................... 117 38 Dilute Russell’s Viper Venom Time (DRVVT) ................................................. 120 38.1 Preparation of Washed Platelets for DRVVT .................................................. 123 39 Platelet Function Testing ........................................................................................ 124 39.1 Clot Retraction .................................................................................................... 125 39.2 Measurement of Platelet Aggregation ............................................................. 126 40 Lyophilization of Plasma ....................................................................................... 135 41 Evaluation and Use of Coagulometers .............................................................. 137 42 Molecular Genetic Analysis .................................................................................. 144 Laboratory Equipment 1 Any laboratory involved in the diagnosis and treatment of bleeding disorders employing some or all of the techniques described in this manual will require a minimum of basic equipment. Note that evaluation and use of semi-automated and fully automated coagulometers are dealt with in Section 41. THE BASIC EQUIPMENT REQUIREMENTS ARE: A 4°C refrigerator for reagent storage Reagents should normally be maintained at 2°C–8°C unless otherwise stated by the manufacturer. A good-quality domestic-grade unit may be adequate. A deep freeze able to maintain at least -35°C A lower temperature, such as -70°C, is useful for more prolonged storage. Clotting factors are stable at this temperature for at least six months (Woodhams et al., 2001). Freezers of -20°C are typically inadequate for storage of plasmas and reagents for many tests of hemostasis. Freezers with an auto defrost cycle are completely unsuitable. Regulated water bath(s) capable of maintaining temperatures of 37°C ± 0.5°C Dry hot blocks may or may not be suitable, depending on the unit. Temperature is normally better maintained in a water bath. A pH meter A light source (for example, an Anglepoise lamp) Stopwatch(es) Calibrated automatic pipettes capable of accurate and precise delivery of sample and reagent volume in the range of 0 µl–200 µl and up to 1000 µl It is important that the accuracy of these is